POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 102 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $5,529,315 | 3.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,230,000 | $11,819,000 | 3.38% |
| Paradigm Biocapital Advisors LP | 2,434,816 | $12,904,525 | 1.52% |
| CROWN ADVISORS MANAGEMENT, INC. | 150,000 | $795 | 0.72% |
| Pentwater Capital Management LP | 5,975,000 | $31,667,500 | 0.56% |
| EcoR1 Capital, LLC | 2,650,000 | $14,045,000 | 0.43% |
| Cormorant Asset Management, LP | 1,150,000 | $6,095 | 0.41% |
| Knott David M Jr | 168,839 | $895 | 0.34% |
| EAM Investors, LLC | 218,305 | $1,157,017 | 0.24% |
| XTX Topco Ltd | 124,036 | $657,391 | 0.14% |